Class information for:
Level 1: VEGF POLYMORPHISMS//VEGF POLYMORPHISM//RS2010963

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
17641 526 36.2 90%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
222 19941 LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 VEGF POLYMORPHISMS Author keyword 8 70% 1% 7
2 VEGF POLYMORPHISM Author keyword 7 67% 1% 6
3 RS2010963 Author keyword 6 100% 1% 4
4 VASCULAR ENDOTHELIAL GROWTH FACTOR GENE Author keyword 3 50% 1% 5
5 VEGF GENE POLYMORPHISM Author keyword 3 60% 1% 3
6 TEAM MOL VIROL ONCOBIOL Address 2 67% 0% 2
7 VEGF GENE Author keyword 2 36% 1% 4
8 405G C Author keyword 1 100% 0% 2
9 HEALTH CARE JUSTICE Author keyword 1 50% 0% 2
10 LUNG GRP MED Address 1 100% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 VEGF POLYMORPHISMS 8 70% 1% 7 Search VEGF+POLYMORPHISMS Search VEGF+POLYMORPHISMS
2 VEGF POLYMORPHISM 7 67% 1% 6 Search VEGF+POLYMORPHISM Search VEGF+POLYMORPHISM
3 RS2010963 6 100% 1% 4 Search RS2010963 Search RS2010963
4 VASCULAR ENDOTHELIAL GROWTH FACTOR GENE 3 50% 1% 5 Search VASCULAR+ENDOTHELIAL+GROWTH+FACTOR+GENE Search VASCULAR+ENDOTHELIAL+GROWTH+FACTOR+GENE
5 VEGF GENE POLYMORPHISM 3 60% 1% 3 Search VEGF+GENE+POLYMORPHISM Search VEGF+GENE+POLYMORPHISM
6 VEGF GENE 2 36% 1% 4 Search VEGF+GENE Search VEGF+GENE
7 405G C 1 100% 0% 2 Search 405G++C Search 405G++C
8 HEALTH CARE JUSTICE 1 50% 0% 2 Search HEALTH+CARE+JUSTICE Search HEALTH+CARE+JUSTICE
9 VEGF PLASMA LEVELS 1 100% 0% 2 Search VEGF+PLASMA+LEVELS Search VEGF+PLASMA+LEVELS
10 VEGF PRODUCTION 1 100% 0% 2 Search VEGF+PRODUCTION Search VEGF+PRODUCTION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 VEGF GENE 78 50% 22% 114
2 FACTOR GENE POLYMORPHISMS 75 59% 16% 84
3 GENDER SPECIFIC ASSOCIATION 23 65% 4% 22
4 FACTOR VEGF GENE 17 70% 3% 14
5 ANGIOGENESIS GENES 12 86% 1% 6
6 C G POLYMORPHISM 6 100% 1% 4
7 PREDICT TUMOR RECURRENCE 3 100% 1% 3
8 FACTOR POLYMORPHISMS 2 67% 0% 2
9 KDR GENE 2 67% 0% 2
10 VEGF GENE POLYMORPHISMS 2 67% 0% 2

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Prognostic and predictive role of vascular endothelial growth factor polymorphisms in breast cancer 2015 1 74 53%
The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors 2009 86 68 49%
Markers of Response for the Antiangiogenic Agent Bevacizumab 2013 82 69 14%
Vascular Endothelial Growth Factor Pathway Polymorphisms as Prognostic and Pharmacogenetic Factors in Cancer: A Systematic Review and Meta-analysis 2012 14 71 62%
Clinical implications of genetic variations in the VEGF system in relation to colorectal cancer 2011 10 64 45%
VEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 update 2013 3 77 52%
Vascular endothelial growth factor and recurrent spontaneous abortion: A meta-analysis 2012 5 29 48%
Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin's lymphoma 2009 8 25 56%
The Role of Vascular Endothelial Growth Factor A Polymorphisms in Breast Cancer 2012 6 90 38%
Pharmacogenetic biomarkers for the prediction of response to antiangiogenic treatment 2012 19 37 19%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 TEAM MOL VIROL ONCOBIOL 2 67% 0.4% 2
2 LUNG GRP MED 1 100% 0.4% 2
3 NORRIS COMPREHENS CANC KECK MED 1 50% 0.4% 2
4 TEAM BIOTECHNOL BIOMAT ORAL ENVIRONM 1 100% 0.4% 2
5 TEAM MEDBIOTECH 1 100% 0.4% 2
6 TEAM MOL BIOL ONCOBIOL 1 100% 0.4% 2
7 BIOQUIM INMUNOL 3 1 50% 0.2% 1
8 DBBS 1 50% 0.2% 1
9 DEV AGINGCHUO KU 1 50% 0.2% 1
10 FARZANEGAN HIGH 2 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000172136 TSU 68//APATINIB//MUCOCUTANEOUS TOXICITIES
2 0.0000170600 PLASMA VEGF//MANCHESTER RENAL GRP//PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR
3 0.0000158747 FLT 1//VEGF RECEPTORS//VEGF165B
4 0.0000128380 EGF POLYMORPHISM//GEFITINIB THERAPY//INTRON 1 POLYMORPHISM
5 0.0000117871 VASOHIBIN 1//VASOHIBIN//VASOHIBIN 2
6 0.0000089497 BRAIN VASCULARITY//NEUROVASCULAR NICHE//BRAIN CAPILLARY DENSITY
7 0.0000082585 ADAPHOSTIN//BONE MARROW MICROVESSEL DENSITY//PEDIAT PEDIAT ONCOL HEMATOL
8 0.0000076177 OREGOVOMAB//AFLIBERCEPT//GI PERFORATION
9 0.0000065491 MICROVESSEL DENSITY//MICROVESSEL COUNT//CHALKLEY
10 0.0000056851 ACUTE REJECTION REACTION//TUMOR ANGIOGENESIS//E S 8